This bill establishes a psilocybin therapeutic use program in Minnesota, allowing individuals aged 21 and older with qualifying medical conditions to access psilocybin under the supervision of registered facilitators. It creates a legal framework for therapeutic use, defining key terms such as "registered patient," "registered facilitator," and "qualifying medical condition." The commissioner of health is tasked with creating operational rules, including eligibility criteria and the registration process for patients and facilitators. The bill also outlines the responsibilities of the commissioner, including data collection for program evaluation and the establishment of an advisory committee, while providing protections against civil and criminal penalties for participants in the program.

Additionally, the bill amends current drug legislation by removing psilocybin from the Schedule I controlled substances list, allowing for its regulated therapeutic use. It introduces provisions for the protection of registered patients, suppliers, and facilitators from discrimination and outlines penalties for violations related to psilocybin. The legislation also emphasizes public education on responsible psilocybin use and mandates training for first responders. Furthermore, it includes data privacy measures to protect personal information collected under the program and establishes annual fees for patient enrollment, with reduced fees for individuals receiving certain disability assistance. Overall, the bill aims to promote safe and informed use of psilocybin while ensuring a structured framework for its therapeutic application.

Statutes affected:
Introduction: 152.02